Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice
Authors:
- 10 June 2022
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 783, 136725
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Rodent models for Alzheimer’s disease drug discoveryExpert Opinion on Drug Discovery, 2015
- Vitamin D and the risk of dementia and Alzheimer diseaseNeurology, 2014
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolismTrends in Biochemical Sciences, 2014
- Vitamin D in Relation to Cognitive Impairment, Cerebrospinal Fluid Biomarkers, and Brain VolumesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2014
- Early Onset Alzheimer’s Disease and Oxidative StressOxidative Medicine and Cellular Longevity, 2014
- Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agentsExpert Review of Neurotherapeutics, 2010
- Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?Free Radical Biology and Medicine, 2008
- The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s diseaseProgress in Neurobiology, 2000
- Imaging Alzheimer's amyloidNature Biotechnology, 2000